What You Should Know:
– A collaborative effort between COTA, PreciseDx, and Baptist Health South Florida seeks to revolutionize breast cancer recurrence risk assessment with the PreciseBreast™ (PDxBr) test. This AI-powered tool holds promise for…
Continue Reading
Table of Contents
Introduction
Study Overview
Implications for Cardiovascular Risk Stratification
Integration into Clinical Practice
Further Research and AI Applications
FAQs
Introduction
Routine mammographic screenings are generally utilized for the detection of breast cancer. However, emerging research, including the study presented by…
Table of Contents
Introduction
Leadership Transition at ScreenPoint Medical
Vision and Expectations Under New Leadership
Impact on Breast Cancer Detection Technology
Reactions and Endorsements
FAQs
Introduction
ScreenPoint Medical, a leading provider of artificial intelligence (AI) solutions for breast cancer detection, has recently…
By Shania Kennedy
May 06, 2024 – Researchers from the University of Texas (UT) Southwestern Medical Center have developed a computational tool to predict breast cancer immunotherapy response by analyzing how cancer and immune cells interact.
The…
What You Should Know: – G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development company, announced a global licensing agreement (excluding the Asia-Pacific…
Continue Reading
What You Should Know:
– G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development company, announced a global licensing agreement (excluding the Asia-Pacific region)…
Continue Reading
Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), have developed an artificial intelligence tool that predicts whether a patient will respond to cancer treatment drugs using individual…
Continue Reading
Discover how deep learning technologies revolutionize breast cancer screening, efficiently identifying false positives while ensuring the detection of true cancer cases. Through rigorous evaluation and validation, these AI-driven tools demonstrate significant reductions in unnecessary…
Continue Reading
By Shania Kennedy
April 12, 2024 – Researchers have developed a deep learning tool capable of reducing false positives without missing true cases of breast cancer identified by screening mammography, according to a study published this…
Continue Reading
What You Should Know: – PreciseDx®, a leader in AI-powered diagnostics for oncology, announces a crucial collaboration with UCLA’s Department of Pathology and Laboratory Medicine. – The research initiative focuses on evaluating PreciseDx’s innovative…
Continue Reading
